Noubar Afeyan is founder and CEO of Flagship Pioneering, a global scientific innovation and company creation platform focused on human and planetary health. He is also co-founder and Board Chairman of Moderna (NASDAQ: MRNA), the pioneering messenger RNA medicines company, as well as of Generate:Biomedicines (NASDAQ: GENB), a pioneer in AI-generated biotherapeutics. Early in his career, he founded and ran PerSeptive Biosystems, a leading biotechnology instrumentation company.
Afeyan holds more than 100 patents and has co-founded more than 100 life science and technology startups over the course of his career. Afeyan completed his doctoral work in biochemical engineering at MIT and his undergraduate studies at McGill University. For more than 20 years he was a senior lecturer at MIT’s Sloan School of Management and a lecturer at Harvard Business School, and he currently serves as a member of the MIT Corporation’s Executive Committee.
Afeyan is co-founder of the Aurora Humanitarian Initiative and several other philanthropic projects.
